Since we discovered the relationship between RIPK4 and the STAT3 signalling pathway and its downstream molecular targets, we next further explored whether RIPK4 inhibits HCC invasion and metastasis through the STAT3 signalling pathway. This evidence concerns the gene STAT3 and hepatocellular carcinoma.